tiprankstipranks
Concert Pharma (CNCE)
NASDAQ:CNCE

Concert Pharma (CNCE) Stock Investors

0 Followers
Based on 625,540 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CNCE
On average, investors allocate 0.00% of their portfolios to CNCE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CNCE

0.3%
Last 7
Days
7.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CNCE, out of 625,540 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CNCE Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$6.01
Opened
0.72%
$5.95
Opened
0.39%
Opened
15.24%
$5.35
Based on the activity of 11,840 investors who made their portfolios public
The table shows changes in CNCE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CNCE Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Gilead Sciences
4.32%
-0.54%
-2.09%
101.15B
Healthcare
General Electric
5.85%
-0.40%
-2.30%
94.83B
Industrial Goods
Crispr Therapeutics AG
3.96%
-0.55%
+0.12%
3.88B
Healthcare
Syros Pharmaceuticals
3.74%
-1.28%
-6.36%
79.98M
Healthcare
Moderna
5.90%
-0.32%
-1.64%
55.64B
Healthcare
Bristol Myers
3.97%
-0.26%
-1.62%
144.61B
Healthcare
Tilray
4.86%
-0.87%
-3.65%
1.66B
Basic Materials
Abbott Labs
3.80%
+0.39%
+1.20%
178.57B
Healthcare
Virgin Galactic Holdings
4.46%
+0.02%
-0.62%
1.52B
Technology
Li Auto
5.29%
+1.97%
+10.13%
24.65B
Consumer Goods
Based on the activity of 625,540 active portfolios
Open your Smart Portfolio

CNCE Investor Analysis

CNCE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.3%
of CNCE holders
are under 35
Average Segment Performance
Average P/E Ratio-
Beta0.00
Dividend Yield0.00%
CNCE investors between 35–55

Between 35–55

18.4%
Last 30 days
Holdings Change
58.8%
of CNCE holders
are between 35–55
Average Segment Performance
Average P/E Ratio-
Beta0.00
Dividend Yield0.00%
CNCE investors over 55

Over 55

14.0%
Last 30 days
Holdings Change
30.9%
of CNCE holders
are over 55
Average Segment Performance
Average P/E Ratio-
Beta0.00
Dividend Yield0.00%
Overview of age group and performance of CNCE stock investors
See who invests in CNCE according to age group and performance.

FAQ

How many retail Investors hold CNCE?
<0.1% of TipRanks' retail investors hold CNCE in their portfolios.
    What is CNCE Investor Sentiment?
    CNCE’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CNCE in the last 7 days?
      ▼ 0.3% of TipRanks' retail investors changed their holding of CNCE in the last 7 days.
        What percentage of retail investors changed their holding of CNCE in the last 30 days?
        ▼ 7.7% of TipRanks' retail investors changed their holding of CNCE in the last 30 days.
          What is the average age of retail investors who hold CNCE?
          The average age of CNCE Holders is between 35–55.
            What other stocks have CNCE investors also bought?
            CNCE Investors also bought GILD, GE, CRSP, SYRS, MRNA, BMY, TLRY, ABT, SPCE, LI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              AMRNAmarin
              ABCAmerisourceBergen
              BDXBecton Dickinson
              BSXBoston Scientific
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis